“One of the biggest problems in the treatment of depression today is a delay in onset of therapeutic effects”
More than 1 in 10 Americans take antidepressants, but these medications can take weeks—and for some patients, months—before they begin to alleviate symptoms. Now, scientists from the University of Chicago have discovered that selectively blocking a serotonin receptor subtype induces fast-acting antidepressant effects in mice, indicating a potential new class of therapeutics for depression. The work was published Oct. 29 in Molecular Psychiatry.
“One of the biggest problems in the treatment of depression today is a delay in onset of therapeutic effects. There has been a great need to discover faster-acting drugs,” said Stephanie Dulawa, PhD, associate professor of psychiatry and behavioral neuroscience at the University of Chicago and senior author of the study.
Delayed onset of antidepressant therapeutics can significantly impact patients, especially those with major depressive disorder, who often spend months switching between ineffective medications. Currently, only two drugs—ketamine and scopolamine—exhibit rapid onset. Due to severe side effects, however, neither is suitable for human use.
In seeking a new class of fast-acting therapeutics, Dulawa and her team tested biological pathways that had previously been shown to generate antidepressant effects but had never been studied for rate of onset. They looked at different subtypes of serotonin receptors, proteins that are binding partners for serotonin, a neurotransmitter that has been shown to regulate mood, memory and appetite.
Of these subtypes, serotonin 2C receptors stood out. Selectively blocking these receptors in mice significantly reduced depression-like behaviors in only five days, compared to a minimum of two weeks for a control antidepressant medication.
“We observed fast-acting therapeutic effects in multiple behavioral tasks after we administered compounds that selectively block serotonin 2C receptors,” said Mark Opal, a graduate student at the University of Chicago and lead author of the paper. “We began our measurements at five days, but we think there’s a possibility it could be effective even sooner than that.”
Serotonin 2C receptors normally inhibit the release of dopamine, another neurotransmitter commonly associated with mood, from certain neurons. When 2C is blocked, the researchers believe, more dopamine is released into regions of the brain such as the prefrontal cortex. The team also observed the induction of biomarkers that indicate antidepressant action.
This is the first new biological mechanism that has shown the ability to rapidly alleviate symptoms of depression since ketamine and scopolamine, and it potentially represents a much safer alternative.
Go deeper with Bing News on:
Fast-Acting Antidepressant
- Sean Kirst: In memory of son lost amid mental health crisis, WNY mom bicycles coast to coast
For Debbie Curtis, this is at the core of her ride – the awareness of how the same thing can happen to anyone, on any day. When it does, she said, there is comfort in knowing so many others have been ...
- How LSD can be used to treat anxiety disorder
A new study shows that LSD is highly effective at treating generalised anxiety disorder for up to 12 weeks with just a single dose. The US Food and Drug Administration has designated this a ...
- Single dose of LSD highly effective at treating anxiety
Having long been considered to have ‘no accepted medical use’, psychedelics are finally being recognised as being beneficial for treating a range of mental health disorders.
- Trainwreck: The Origins and Genetics
In this comprehensive guide, we'll delve into the origins and genetics of Trainwreck, uncovering the fascinating story behind this strain.
- Funny Pages to Phil Spector: the seven best films to watch on TV this week
Owen Kline’s coming-of-age tale is very funny and endlessly excruciating, and Al Pacino plays the music producer on trial for murder with relish ...
Go deeper with Google Headlines on:
Fast-Acting Antidepressant
[google_news title=”” keyword=”Fast-Acting Antidepressant” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Antidepressants
- Can Genetic Testing Reveal the Right Antidepressant?
Pharmacogenetic testing is also insightful about how non-pharmaceutical interventions, such as dietary supplements like l-methylfolate or magnesium, might benefit patients. The test even offers ...
- What You Really Need to Know About Antidepressants
More research is needed to better understand how antidepressants work and their efficacy, especially when taken over the course of several years.
- Suddenly coming off antidepressants can cause emotional, cognitive and social difficulties
And so have the prescription of antidepressants. Often, alarmist headlines announce these numbers, as if antidepressants are inherently a bad thing. However, the rise in prescriptions over the ...
- Side effects of 'magic mushrooms' similar to regular antidepressants
People in a new study who took psilocybin often experienced headache, nausea, anxiety, dizziness and elevated blood pressure -- side effects similar to those seen with regular antidepressants.
- Magic mushrooms can treat medication-resistant depression—but are they safe?
New research suggests psilocybin has similar side effects to traditional antidepressants. Commonly referred to as "magic mushrooms," psilocybin is a promising alternative treatment for people with ...
Go deeper with Google Headlines on:
Antidepressants
[google_news title=”” keyword=”antidepressants” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
